Under phase 2 of vaccine drive, govt aims to vaccinate 10 crore citizens. Shots to be free of cost at govt facilities while price for those at private facilities to be decided.
Intranasal vaccine BBV154 is being developed by the Hyderabad-based Bharat Biotech. New Delhi: Indian vaccine developer Bharat Biotech is working towards developing a nasal vaccine against the deadly Covid-19 virus. This, according to medical experts, may be a game-changer in the field of vaccination against a virus
Read more about Andhra Pradesh begins second phase of Covid-19 vaccination on Business Standard. Andhra Pradesh on Saturday began administering the second dose of coronavirus vaccine to frontline workers